Norway Medical only

Legal Framework

Recreational cannabis remains fully illegal in Norway. Under the Penal Code and the Medicines Act, possession and use of narcotics, including cannabis, is punishable by up to 6 months' imprisonment, though in practice small quantities (commonly cited as up to around 15 grams) are usually handled with fines rather than prosecution, especially for first-time offenders.

In February 2021, the Norwegian government proposed a broader decriminalization reform ("rusreform") that would have removed criminal penalties for possession of small quantities of drugs, including up to 10 grams of cannabis, for personal use. Parliament rejected the bill in April 2021 by a narrow margin (Wikipedia). Following Supreme Court rulings, Norway's Attorney General issued guidance in May 2022 stating that people who use drugs should generally not be punished for possession of small amounts intended for their own use — a shift in prosecutorial practice rather than a change in the underlying law.

In 2025, the government advanced a second-stage prevention-and-treatment reform: the Storting adopted changes to the Penal Code and Medicines Act in June 2025, introducing a system of simplified, non-criminal-record fines for minor adult drug offenses and steering under-18s toward municipal advisory units instead of prosecution (The Cannigma). This reform explicitly stopped short of decriminalization or legalization — personal possession remains formally illegal, and the government has ruled out a legal recreational market.

Medical Cannabis Program

Norway does not have a standard medical cannabis prescribing system. Access runs through Norway's medicines regulator, the Norwegian Directorate for Medicinal Products (Direktoratet for medisinske produkter, DMP — formerly Statens legemiddelverk), via a "special permit, named patient" exemption route (godkjenningsfritak) for medicines without Norwegian marketing authorization (DMP).

Sativex and Epidyolex are the only cannabis-based medicines with full Norwegian marketing authorization and can be prescribed directly by any physician licensed to prescribe Group A medicines. For other cannabis products — such as Bedrocan-type flower or dronabinol — physicians can apply for a named-patient exemption; products containing up to 1% THC can be requested by any qualifying prescriber, while products above 1% THC require a hospital specialist to apply. Applicants must show that standard, approved treatments have already been tried without sufficient effect, typically for patients with severe, treatment-resistant pain or related conditions. Exemptions are granted for a specific quantity or period, up to a maximum of one year, and DMP typically processes applications within about three working days. This remains a narrow, case-by-case exception system rather than a general prescribing framework, and patient numbers are correspondingly small.

Traveling with Medical Cannabis

No official Norwegian statement specifically addressing foreign patients bringing prescribed medical cannabis into the country was found in available sources. Norway participates in the Schengen area (though it is not an EU member), so the Article 75 certificate framework — allowing travelers to carry a 30-day supply of a controlled medicine prescribed in another Schengen state, certified by the home-country authority — should apply in principle. This is not, however, explicitly confirmed for cannabis-based products by a Norwegian authority in the sources reviewed. Given that Norway's own domestic access is limited to registered products (Sativex, Epidyolex) plus narrow named-patient exemptions for flower, travelers carrying unregistered cannabis-flower products should not assume equivalent treatment to Sativex/Epidyolex at the border, and should verify directly with DMP before travel.

Recent Developments

• April 2021: Parliament narrowly rejects the "rusreform" decriminalization bill.
• May 2022: Attorney General issues guidance discouraging prosecution of personal-use possession following Supreme Court case law.
• 10 April 2025: Government presents Part II of its prevention and treatment reform.
• 20 June 2025: Storting adopts changes introducing simplified fines for minor adult drug offenses and diverting under-18s to municipal advisory units, while explicitly maintaining the ban on personal possession and ruling out a legal cannabis market.

Frequently Asked Questions

Is cannabis decriminalized in Norway?
No. A 2021 decriminalization bill was rejected, and while a 2025 reform introduced simplified fines and reduced prosecution for minor cases, personal possession remains formally illegal.

How do Norwegian patients get medical cannabis?
Through Sativex/Epidyolex prescriptions from any qualified physician, or via a case-by-case "special permit, named patient" exemption from DMP for other products, generally after other treatments have failed.

Can I bring my foreign medical cannabis prescription into Norway?
Likely possible in principle under the Schengen Article 75 framework since Norway is a Schengen member, but this is not explicitly confirmed for cannabis products by a Norwegian authority — verify with DMP before traveling.

What happens if I'm caught with a small amount of cannabis in Norway?
Formally, possession can carry up to 6 months' imprisonment, but in practice small personal-use quantities (roughly up to 15 grams) are typically handled with fines, and prosecutorial guidance since 2022 further discourages punishing personal-use possession.